Subscribe Free
in Air Transport

Research backs rapid testing for safe and efficient restart of air travel

Posted 30 March 2021 · Add Comment

IATA has urged governments to accept best-in-class rapid antigen tests in fulfilment of COVID -19 testing requirements following the publication of new research by OXERA and Edge Health.

 

Image:  IATA

The OXERA-Edge Health report commissioned by IATA, found that antigen tests are:

 

    Accurate: the best antigen tests provide broadly comparable results to PCR tests in accurately identifying infected travellers. The BinaxNOW antigen test, for example, misses just one positive case in 1000 travellers (based on an infection rate of 1% among travellers). And it has similarly comparable performance to PCR tests in levels of false negatives.

    Convenient: processing times for antigen tests are 100 times faster than for PCR testing

    Cost-efficient: antigen tests are, on average, 60% cheaper than PCR tests.

 

“Restarting international aviation will energize the economic recovery from COVID-19. Along with vaccines, testing will play a critical role in giving governments the confidence to re-open their borders to travellers. For governments, the top priority is accuracy. But travellers will also need tests to be convenient and affordable. The OXERA-Edge Health report tells us that the best-in-class antigen tests can tick all these boxes. It’s important for governments to consider these findings as they make plans for a re-start,” said Alexandre de Juniac, IATA’s director general and CEO.

Options

 

Testing requirements are currently fragmented, which is confusing to travellers. Moreover, many governments do not allow rapid testing. If the only options available for travellers are PCR tests, these come with significant costs disadvantages and inconvenience. And in some parts of the world, PCR testing capacity is limited, with first priority correctly given to clinical use.

 

“Travellers need options. Including antigen testing among acceptable tests will certainly give strength to the recovery. And the EU’s specification of acceptable antigen tests offers a good baseline for wider international harmonization of acceptable standards. We now need to see governments implement these recommendations. The goal is to have a clear set of testing options that are medically effective, financially accessible, and practically available to all prospective travellers,” said de Juniac.

 

Costs

 

If rapid tests are not an option for travellers, significant cost and convenience barriers are created. The OXERA-Edge Health report presented the following analysis:

 

    The cost of PCR testing can completely alter the economics of travel. A family of four traveling from the UK to the Canary Islands will take a total of 16 tests at a total cost of around GBP1,600 or EUR1,850 - a premium of 160% on top of the average air fare.

    A typical London-Frankfurt business trip sees a cost increase of 59% with the PCR test requirement.

    The modelling shows that based on five routes studied (London-New York, London-Frankfurt, UK-Singapore, UK-Pakistan and Manchester-Canary Islands) the cost impact of PCR testing will reduce demand by an average of 65%. Replacing PCR with antigen testing would still have a cost impact on demand, but at 30%.

 

Financial barriers will dampen traveller sentiment which already displays some weakness. In a February poll of travellers, 58% said that they will travel less for leisure once the pandemic is contained. The same poll saw 62% of business travellers say they would be traveling less.

Convenience

 

In addition to dramatically shorter processing times for antigen testing when compared to PCR, the report also pointed to the scarcity of PCR tests. Current spare PCR testing capacity in the UK, for example, would cover only 25% of 2019 passenger levels. This could cause bottlenecks as and when passenger numbers rebound. Adding antigen testing as an acceptable option would help to alleviate this.

 

‘When international travel reopens testing is likely to remain part of the strategy for controlling COVID. The type of testing regime chosen will make the difference in how quickly the travel industry recovers. The choice of a rapid test would be a real boost to the global travel and international business community, and our research shows it can be as effective as other testing regimes and as effective as a ten-day quarantine,’ said Michele Granatstein, Partner at Oxera and Head of its Aviation Practice.

 

“We are already seeing rapid testing becoming commonplace in non-travel settings such as schools and workplaces. Extending its use to travel is a logical step. Science backs this up. In real world conditions, antigen testing is as effective as PCR testing in reducing the risk of cross-border transmission. Meanwhile the cost and bureaucracy of PCR tests adds huge burdens to families and businesses looking to travel. These are important considerations in preparing for a successful re-start,” said de Juniac.

Other Stories
Advertisement
Latest News

Gulf Air to transform Falconflyer programme

Gulf Air has selected IBS Software as a partner to enhance its Falconflyer loyalty programme (FFP) and provide Gulf Air with the flexibility to adapt its Falconflyer programme to meet the needs of travellers and enhance its members

NAS and World Economic Forum partner to share traveller vaccine records

National Aviation Services (NAS) has partnered with the World Economic Forum to enhance safe air travel by using its KuwaitMosafer platform to share Kuwait’s vaccine records with countries and airlines across the globe.

Etihad Airways celebrates the UAE’s Year of the 50th

Etihad Airways has unveiled a year-long programme in celebration of the 50 years since the nation was established. The programme will launch in three phases, focusing on the past, the present and looking forward to the future.

Bombardier completes 100th Global 7500 business jet wing

Bombardier is celebrating the completion of the 100th wing for its Global 7500 business jet, a significant milestone for the industry-leading aircraft and for the company’s facility in Red Oak, Texas, where the advanced wing is

Emirates and Sheraa sign MOU

Emirates has signed an MoU with Sharjah Entrepreneurship Center (Sheraa) to strengthen and expand the entrepreneurship ecosystem in the UAE.

Sanad closes US$ 55M financing deal with Commercial Bank of Dubai

Sanad Capital, a wholly-owned subsidiary of Mubadala Investment Company and the global aerospace engineering and leasing solutions leader, has closed a US$ 55 million debt financing deal with the Commercial Bank of Dubai, one of the

EDGE SK2601300621
See us at
Aviation MENA 2021World Defence Show 2022DAS21_BTAviation Africa 2021 BTNN